Aurobindo Gets USFDA Nod for Generic Asthma Medication
Nov 30, 2023 14:54
Aurobindo Pharma's subsidiary receives USFDA approval to market a generic asthma medication, Budesonide Inhalation Suspension, for children aged 12 months to 8 years. The product is expected to launch in FY25.
New Delhi, Nov 30 (PTI) Aurobindo Pharma on Thursday said its subsidiary has received approval from the US health regulator to market a generic medication to treat asthma in children.
Eugia Pharma Specialities, a wholly-owned subsidiary of the company, has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Budesonide Inhalation Suspension, the Hyderabad-based drug firm said in a regulatory filing.
The company's product is therapeutically equivalent to Astrazeneca Pharmaceuticals LP's Pulmicort Repsules Inhalation Suspension, it added.
The product, indicated for treatment of asthma and as prophylactic therapy in children of age 12 months to 8 years, is expected to be launched in FY25, Aurobindo Pharma said.
As per IQVIA data, the approved product has an estimated market size of USD 226.4 million for the 12 months ended September 2023.
Shares of Aurobindo Pharma were trading 1.51 per cent up at 1,036.55 apiece on the BSE.
Home »
Market News » Aurobindo Gets USFDA Nod for Generic Asthma Medication
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
MORE NEWS
Sebi to Restrict Live Market Data for Education
Sebi to change rules prohibiting live market data for investor education. Focus on past...
India Agri Growth Forecast Lowered to 4% in FY26
Niti Aayog member Ramesh Chand estimates India''s agriculture growth at 4% in FY26,...
Adani Group: 48-MW Data Center in Telangana
Adani Group invests Rs 2,500 cr in Telangana for a 48-MW AI green data center. Total...
Sebi Overhauls Merchant Banker Rules: Key Changes
Sebi introduces new rules for merchant bankers, including capital adequacy, liquid net...
Waaree Solar Bags 288 MWp Module Order in US
Waaree Solar Americas secures 288 MWp solar module order from Sabanci Renewables for...
ISI Restructuring: New Law Needed, Says Minister
Minister Rao Inderjit Singh says new law is essential to restructure ISI as a body...
Sensex, Nifty Plunge on Profit Booking, FII...
Sensex tanks 610 pts, Nifty below 26k as investors book profits amid FII selling. Fed...
Specialty Surgical Oncology Secures USD 2.8M...
Specialty Surgical Oncology (SSO) secures USD 2.8 million funding from Everhope...
Rupee Falls to 90.09 Against US Dollar
Rupee depreciates to 90.09 against the dollar amid high crude oil prices and foreign...
New ITR Forms by FY28 Under Income Tax Act, 2025
Govt to notify new ITR forms based on Income Tax Act, 2025 before FY28. Simplification...
Read More »